Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

17.62
+0.86005.13%
Post-market: 17.620.00000.00%19:30 EDT
Volume:902.96K
Turnover:15.74M
Market Cap:2.05B
PE:-13.47
High:17.64
Open:16.98
Low:16.92
Close:16.76
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:0.47
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:6.07
PE(LYR):-14.42

Loading ...

Novocure Q2 Pretax Profit USD -12.452 Million

THOMSON REUTERS
·
Jul 23

Novocure Q2 Revenue USD 183.584 Million VS. Ibes Estimate USD 172.4 Million

THOMSON REUTERS
·
Jul 23

Novocure Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 23

Earning Preview: NovoCure revenue is expected to increase by 12.00%, institutions lean cautious on near-term profitability

Earnings Agent
·
Jul 17

Analysts Have Conflicting Sentiments on These Healthcare Companies: COMPASS Pathways (CMPS), NovoCure (NVCR) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Jul 13

Novocure Price Target Announced at $17.00/share by JP Morgan

Dow Jones
·
Jul 13

J.P. Morgan Sticks to Its Hold Rating for NovoCure (NVCR)

TIPRANKS
·
Jul 13

Novocure Ltd : JP Morgan Resumes Coverage with Neutral Rating; Target Price $17

THOMSON REUTERS
·
Jul 13

Novocure to Report Q2 Results, Host Conference Call and Webcast

Reuters
·
Jul 01

Novocure to Report Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 01

Novocure Wins CE Mark for Optune Pax in Locally Advanced Pancreatic Cancer Treatment

Reuters
·
Jun 30

Novocure’s Optune Pax® Receives Ce Mark for the Treatment of Locally Advanced Pancreatic Cancer

THOMSON REUTERS
·
Jun 30

Novocure - to Launch Optune Pax in Germany in Coming Weeks

THOMSON REUTERS
·
Jun 30

Wedbush Initiates a Hold Rating on NovoCure (NVCR)

TIPRANKS
·
Jun 23

Analysts Are Bullish on These Healthcare Stocks: NovoCure (NVCR), Ocular Therapeutix (OCUL)

TIPRANKS
·
Jun 22

Top Midday Decliners

MT Newswires Live
·
Jun 19

Sector Update: Healthcare Stocks Decline Thursday Afternoon

MT Newswires Live
·
Jun 19

NovoCure Down Nearly 18%, On Track for Largest Percent Decrease Since July 2025 -- Data Talk

Dow Jones
·
Jun 19

Novocure Price Target Cut to $46.00/Share From $48.00 by HC Wainwright & Co.

Dow Jones
·
Jun 19

BUZZ-U.S. STOCKS ON THE MOVE-Kardigan, Energy companies

Reuters
·
Jun 18